PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40121C00094Fare-net — Exponent, Inc

Exponent, Inc holds $34.7M across 70 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Exponent, Inc

Recipient

Sep 29, 2026

PoP end

$1.6M

Obligated

$1.9M

Potential

541519

NAICS

DF01

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Exponent, Inc — $90

Contract facts

NONE

Contract number75F40121C00094

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentExponent, Inc

CAGE1NG83

UEIF1NXQ68RNFM4

NAICS541519

PSCDF01

Place of performanceBERWYN HEIGHTS MD

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startAug 26, 2021

PoP end (current)Sep 29, 2026

PoP end (w/ options)Sep 29, 2027

Obligated$1.6M

Current value$1.7M

Potential value$1.9M

FARE-NET is a federal NONE award for Fda Office Of Acq Grant Svcs held by Exponent, Inc. Estimated value $1.9M ($1.6M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2027). Last award drew 1 bidder. Place of performance: BERWYN HEIGHTS MD.

Recompete timing

Public

● Expiring in 39 days

Current PoP ends Sep 29, 2026 (39 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Exponent, Inc — $34.7M obligated across 70 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($34.7M) · all agencies · Top 4 shown (87%); remaining ~13% is other agencies.

Department of Defense (DOD)$20.4M · 59%Department of Transportation (DOT)$4.5M · 13%Department of State (DOS)$3.5M · 10%Department of Justice (DOJ)$1.8M · 5%

Open full company profile →

Related awards

Same incumbent

W50RAJ24F0017

TASK TYPE 4 - ON INDIVIDUAL FFP TI

$4.0M

Sep 20, 2026

693JJ924F00037N

THIS IS A NEW REQUISITION. IN RECENT YEARS, ADVANCEMENTS IN MAPPING HAVE ALLOWED FOR TECHN…

$912K

Oct 31, 2026

19AQMM22F0125

SCHEDULING AND REA SUPPORT SERVICES FOR THE MILAN NCC PROJECT.

$643K

Mar 5, 2027

693JJ925F00013N

NEW TO AGAINST THE NEW HUMAN FACTORS IDIQ (NOT YET AWARDED) STARTING SYSTEM, BTSI, AND GEA…

$480K

Mar 19, 2027

693JJ924F00138N

NEW TASK ORDER UNDER VESS IDIQ

$468K

Mar 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40121C00094?

75F40121C00094 (Fare-net) is a Fda Office Of Acq Grant Svcs award with a potential value of $1.9M, currently held by Exponent, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40121C00094?

Fda Office Of Acq Grant Svcs awarded 75F40121C00094 to Exponent, Inc (potential $1.9M).

Who is the incumbent on 75F40121C00094?

Exponent, Inc is the incumbent with $34.7M across 70 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does Exponent, Inc’s 75F40121C00094 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 30, 2025